FDA Revokes Avastin for Breast Cancer Use

Updated:

Loading
The FDA has announced that the blockbuster drug Avastin should no longer be used in advanced breast cancer patients because there's no proof that it extends their lives and it presents dangerous side effects. (Nov. 18)